A new U.S. initiative called Rare Disease Cures Accelerator–Data and Analytics Platform — dubbed RDCA–DAP — aims to accelerate…
Bionews Staff
Bionews, the owner and publisher of this site, employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, who ensure stories are well-written and easy to understand. Our stories undergo a comprehensive fact-checking and editing process to confirm accuracy, objectiveness, and thoroughness in order to best serve our audience of patients and caregivers.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Bionews Staff
A newly launched non-profit institute is seeking to advance research, and the development of new therapies, for people with rare…
Participation in clinical trials exposes rare disease patients to financial, physical, and emotional pressures, according to the results of a…
The National Organization for Rare Disorders, known as NORD, was named an official charity partner of the 2021 TCS…
The National Alliance for Caregiving, in partnership with Global Genes, has issued a free guidebook, available online, that…
Registration is now open for Global Genes‘Â 2021 RARE Patient Advocacy Summit. This year’s hybrid event will be livestreamed…
Registration is now open for the 2021 Rare Diseases and Orphan Products Breakthrough Summit, which will be held virtually…
More than 600 people participated in the 10th annual Rare Disease Week on Capitol Hill 2021, held virtually July…
The National Organization for Rare Disorders (NORD) is applauding the Biden administration for announcing a rule to protect…
AllianceRx Walgreens Prime, a specialty and home delivery pharmacy, is partnering with TailorMed, a healthcare technology company, to help lower…